Carl Zeiss Meditec AG (AFX)
Carl Zeiss Meditec AG is an integrated medical technology company. It operates in the Ophthalmology and Microsurgery business division. The Ophthalmology offers complete solutions for treating the four main eye ailments: vision defects, cataract, glaucoma and retinal disorders. The Ophthalmic equipment and systems offered by the company handle the diagnosis, progress monitoring, treatment and follow-up treatment of different ophthalmic syndromes. The Microsurgery offers surgical microscopes and visualization solutions for ear, nose and throat surgery or neurosurgery. The products are mainly used as support equipment for the removal of tumours as well as the treatment of vascular diseases and functional disorders. The company was founded on July 4, 2002 and is headquartered in Jena, Germany.
|Market Price at 17-11-2017||46,84 €|
|Price to Earnings Ratio||28,16|
|Market Capitalisation||4.188,92 € (million)|
|Return on Equity (ROE)||12,33%|